| Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe N Mafirakureva, B Dzingirai, MJ Postma, M van Hulst, S Khoza AIDS care 28 (7), 904-912, 2016 | 52 | 2016 |
| Profiles of blood and blood component transfusion recipients in Zimbabwe N Mafirakureva, S Khoza, O Hassall, BE Faragher, I Kajja, DA Mvere, ... Blood transfusion 13 (4), 600, 2015 | 52 | 2015 |
| Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis N Mafirakureva, S Khoza, DA Mvere, MLE Chitiyo, MJ Postma, ... Blood Transfusion 12 (3), 362, 2014 | 44 | 2014 |
| Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis AG Lim, JG Walker, N Mafirakureva, GG Khalid, H Qureshi, H Mahmood, ... The Lancet Global Health 8 (3), e440-e450, 2020 | 40 | 2020 |
| The costs of producing a unit of blood in Z imbabwe N Mafirakureva, H Nyoni, SZ Nkomo, JS Jacob, R Chikwereti, Z Musekiwa, ... Transfusion 56 (3), 628-636, 2016 | 31 | 2016 |
| The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a … PJ Dodd, N Mafirakureva, JA Seddon, CF McQuaid The Lancet Global Health 10 (7), e1034-e1044, 2022 | 27 | 2022 |
| Cost and cost‐effectiveness of a simplified treatment model with direct‐acting antivirals for chronic hepatitis C in Cambodia JG Walker, N Mafirakureva, M Iwamoto, L Campbell, CS Kim, RA Hastings, ... Liver International 40 (10), 2356-2366, 2020 | 22 | 2020 |
| Population pharmacokinetic-pharmacodynamic modeling of haloperidol in patients with schizophrenia using positive and negative syndrome rating scale VP Reddy, M Kozielska, M Johnson, N Mafirakureva, A Vermeulen, J Liu, ... Journal of clinical psychopharmacology 33 (6), 731-739, 2013 | 22 | 2013 |
| Xpert Ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis N Mafirakureva, E Klinkenberg, I Spruijt, J Levy, D Shaweno, P De Haas, ... BMJ open 12 (7), e058388, 2022 | 15 | 2022 |
| Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Z imbabwe N Mafirakureva, T Mapako, S Khoza, JC Emmanuel, L Marowa, D Mvere, ... Transfusion 56 (12), 3101-3111, 2016 | 15 | 2016 |
| An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost … N Mafirakureva, J Stone, H Fraser, Y Nzomukunda, A Maina, AW Thiong'o, ... Addiction 117 (2), 411-424, 2022 | 14 | 2022 |
| Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar LK Marquez, A Chaillon, KP Soe, DC Johnson, JM Zosso, A Incerti, ... BMJ global health 6 (2), e004181, 2021 | 14 | 2021 |
| Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic hepatitis C virus in a primary care setting in Karachi, Pakistan N Mafirakureva, AG Lim, GG Khalid, K Aslam, L Campbell, H Zahid, ... Journal of Viral Hepatitis 28 (2), 268-278, 2021 | 13 | 2021 |
| Cost-effectiveness of mass screening for hepatitis C virus among all inmates in an Irish prison Z Ward, N Mafirakureva, J Stone, M Keevans, G Betts-Symonds, ... International Journal of Drug Policy 96, 103394, 2021 | 11 | 2021 |
| Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges B Dzingirai, L Katsidzira, CMJ Matyanga, MJ Postma, M van Hulst, ... Journal of viral hepatitis 28 (7), 994-1002, 2021 | 9 | 2021 |
| Modelling the impact of prevention and treatment interventions on HIV and hepatitis C virus transmission among people who inject drugs in Kenya J Stone, H Fraser, JG Walker, N Mafirakureva, B Mundia, C Cleland, ... MedRxiv, 2021.02. 02.21251008, 2021 | 9 | 2021 |
| Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya J Stone, H Fraser, JG Walker, N Mafirakureva, B Mundia, C Cleland, ... AIDS 36 (15), 2191-2201, 2022 | 8 | 2022 |
| Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial M Bonnet, A Vasiliu, BK Tchounga, B Cuer, K Fielding, B Ssekyanzi, ... The Lancet Global Health 11 (12), e1911-e1921, 2023 | 6 | 2023 |
| A systematic approach for reviewing research capacity within Zimbabwe's national blood service T Mapako, N Mafirakureva, M Mutenherwa, G Bvuma, DA Mvere, ... ISBT Science Series 11 (2), 110-117, 2016 | 5 | 2016 |
| The evaluation of blood donor deferral causes in Zimbabwe N Mafirakureva, S Khoza, M Van Hulst, MJ Postma, DA Mvere Vox Sanguinis 105, 97, 2013 | 5 | 2013 |
